Lower levels of CD4 and IL-10 mRNA in the lungs of TB-DM patients after treatment, but higher expression of CD8 and TNF-α are other important findings of the study, which may possibly explain the persistence seen in pulmonary inflammation during anti-TB therapy. This evidence concerns the gene CD8A and tuberculosis.